NCT03383978
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03383978
Title Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma (CAR2BRAIN)
Acronym CAR2BRAIN
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Johann Wolfgang Goethe University Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Neurochirurgische Klinik, Universitätsklinikum Heidelberg RECRUITING Heidelberg Baden-Wurttemberg 69120 Germany Details
Neurochirurgische Klinik, Universitätsmedizin Mannheim RECRUITING Mannheim Baden-Wurttemberg 68167 Germany Details
Neurochirurgische Klinik, Universitätsmedizin Mainz RECRUITING Mainz Rhineland-Palatinate 55131 Germany Details
Johann W. Goethe University Hospital, Department of Neurosurgery RECRUITING Frankfurt 60590 Germany Details
Johann W. Goethe University Hospital, Senckenberg Institute of Neurooncology RECRUITING Frankfurt 60590 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field